glp-1 science and the kidney: from physiology to pharmacology and outcomes in diabetes 🚨 GLP-1 medications are quietly

Thiara, who is also an assistant professor of clinical medicine, says some patients stick to a lower dose because they cant tolerate more GLP-1 medication, which is fine

STEP and SURMOUNT trials didnt standardize specific injection times, and post-hoc analyses found no differences in efficacy by time of day

[DOI] [PMC free article] [PubMed] [Google Scholar] 97.Bohm M, Reil JC, Deedwania P, Kim JB, Borer JS

New delivery methods like GLP-1 patches and oral versus injectable formulations are also changing how these medications reach patients, which could indirectly affect eligibility standards as access models evolve

However, recent research has revealed a potentially groundbreaking application: using GLP-1 receptor agonists to curb addiction to substances such as alcohol, nicotine, and opioids

Together, these studies help shape safety protocols, particularly for patients with more complex CKD cases